<DOC>
	<DOC>NCT02029547</DOC>
	<brief_summary>This study is designed to validate the Japanese electronic florbetapir (18F) interpretation training program intended for post-approval implementation in Japan.</brief_summary>
	<brief_title>Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese Physicians</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Japanese Society of Nuclear Medicine (JSNM) Positron Emission Tomography (PET) Certified Nuclear Medicine Physician Minimal handson experience and no formal training in the visual interpretation of florbetapir (18F) brain PET scans Minimal handson experience and no formal training in the quantitation of florbetapir (18F) brain PET scans Prior handson experience or formal training in the visual interpretation and/or quantitation of florbetapir (18F) PET scans</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>